Inhibitory effects of selenium on telomerase activity and hTERT expression in cadmium-transformed 16HBE cells

Biomedical and Environmental Sciences

Volumn 20, Issue 4, 2007, Pages 307-312

  Chen, Hua Jie ^b   Yu, Ri An ^a   He, Ling Fei ^a   An, She Juan ^b   Wu, Zhi Gang ^b   Yang, Ke Di ^b   Chen, Xue Min ^b  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cadmium; Human telomerase reverse transcriptase; Selenium; Telomerase

Indexed keywords

CADMIUM; MESSENGER RNA; PRIMER DNA; SODIUM SELENITE; TELOMERASE; TERT PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; DRUG ANTAGONISM; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CADMIUM; CELL LINE, TRANSFORMED; DNA PRIMERS; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM SELENITE; TELOMERASE;

EID: 34548844200     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Waisberg M, Joseph P, Hale B, et al. (2003). Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192(2-3), 95-117.
2. IARC monographs on the evaluation of the carcinogenic risks to humans (1993). Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry, Vol. 58. IARC Scientific Publications, pp. 119-237.
3. Nawrot T, Plusquin M, Hogervorst J, et al. (2006) Environmental exposure to cadmium and risk of cancer: a prospective population-based study. Lancet Oncol 7(2), 119-126.
4. WAF1/CIP1 in selenite-induced apoptosis of regenerating liver. Eur J Pharmacol 471(1), 1-8.
5. El-Bayoumy K (2001). The protective role of selenium on genetic damage and on cancer. Mutat Res 475(1-2), 123-139.
6. Bjorkhem-Bergman L, Torndal U B, Eken S, et al. (2005). Selenium prevents tumor development in a rat model for chemical carcinogenesis. Carcinogenesis 26(1), 125-131.
7. Clark L C, Dalkin B, Krongrad A, et al. (1998). Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81(5), 730-734.
8. Gabourdes M, Bourgine V, Mathis G, et al. (2004). A homogeneous time-resolved fluorescence detection of telomerase activity. Anal Biochem 333(1), 105-113.
9. Blasco M A, Rizen M, Greider C W, et al. (1996). Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 12(6), 200-204.
10. Greenberg R A, Allsopp R C, Chin L, et al. (1998). Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16(13), 1723-1730.
11. Darimont C, Zbinden I, Avanti O, et al. (2003). Reconstitution of telomerase activity combined with HPV-E7 expression allow human preadipocytes to preserve their differentiation capacity after immortalization. Cell Death Differ 10(9), 1025-1031.
12. Xu D, Gruber A, Bjorkholm M, et al. (1999). Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br J Cancer 80(8), 1156-1161.
13. Choi S H, Im E, Kang H K, et al. (2005). Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells. Cancer Lett 227(2), 153-162.
14. Lee J H, Cheong J, Park Y M, et al. (2005). Down-regulation of cyclooxygenase-2 and telomerase activity by beta-lapachone in human prostate carcinoma cells. Pharmacol Res 51(6), 553-560.
15. Wang Q, Bai Z, Li X, et al. (2004). The evidences of human orphan receptor COUP-TFII inhibiting telomerase activity through decreasing hTERT transcription. Cancer Lett 214(1), 81-90.
16. Wang M, Wei L, Lei Y X (2005). Malignant transformation of human bronchial epithelial cell line induced by cadmium chloride. Chin Occup Med 32(6), 2-4. (In Chinese)
17. Kim S C, Cho M K, Kim S G (2003). Cadmium-induced non-apoptotic cell death mediated by oxidative stress under the condition of sulfhydryl deficiency. Toxicol Lett 144(3), 325-336.
18. Shimojima M, Komine F, Hisatomi H, et al (2004). Detection of telomerase activity, telomerase RNA component, and telomerase reverse transcriptase in human hepatocellular carcinoma. Hepatol Res 29(1), 31-38.
19. Thirunavukkarasu C, Sakthisekaran D (2003). Stabilization of membrane bound enzyme profiles by sodium selenite in N-nitrosodiethylamine induced and phenobarbital promoted hepatocarcinogenesis in rats. Biomed Pharmacother 57(3-4), 117-123.
20. Xu D, Popov N, Hou M, et al. (2001). Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc Natl Acad Sci 98(7), 3826-3831.
21. Wu K J, Grandori C, Amacker M, et al. (1999). Direct activation of TERT transcription by c-MYC. Nat Genet 21(2), 220-224.
22. Casillas M A, Brotherton S L, Andrews L G, et al. (2003). Induction of endogenous telomerase (hTERT) by c-Myc in WI-38 fibroblasts transformed with specific genetic elements. Gene 316, 57-65.
23. McMurray H R, McCance D J (2003). Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J Virol 77(18), 9852-9861.
24. Oh S, Song Y H, Yim J, et al. (2000). Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 19(11), 1485-1490.
25. Gunes C, Lichtsteiner S, Vasserot A P, et al. (2000). Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad 1. Cancer Res 60(8), 2116-2121.
26. Rama S, Suresh Y, Rao A J (2003). TGF β1 induces multiple independent signals to regulate human trophoblastic differentiation: mechanistic insights. Mol Cell Endocrinol 206(1-2), 123-136.
27. Ancelin K, Brunori M, Bauwens S, et al. (2002). Targeting assay to study the cis functions of human telomeric proteins: evidence for an inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2. Mol Cell Biol 22(10), 3474-3487.
28. Smogorzewska A, van Steensel B, Bianchi A, et al. (2000). Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20(5), 1659-1668.